Expression of soluble allo-MHC class I antigen in vivo suppresses IL-2 production by allo-reactive helper T cells.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Transplantation Proceedings

• Publication date

  1999-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0041-1345(98)01749-7PMID 10083316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I molecules.

  1998cited by this paper
• Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells.

  1997cited by this paper
• Secreted donor-MHC class I antigen prolongs liver allograft survival and inhibits recipient anti-donor cytotoxic T lymphocyte responses.

  1997cited by this paper
• Dominant infiltration by TH2 cells into grafts following treatment with anti-CD4 monoclonal antibody.

  1997cited by this paper

• Survival and allograft rejection rates after combined heart and kidney transplantation in comparison with heart transplantation alone.

  2011cites this paper
• Soluble allogeneic MHC class I molecule gene transfer promotes CTL apoptosis in vivo.

  2001cites this paper
• Soluble donor MHC class I gene therapy prevents accelerated heart allograft rejection in actively sensitized rat recipients.

  2001cites this paper
• Soluble donor MHC class I gene transfer to thymus promotes allograft survival in a high-responder heart transplant model

  2000cites this paper
• Soluble donor MHC class I gene transfer to thymus promotes allograft survival in a high‐responder heart transplant model

  2000cites this paper
• Effective Use of Donor MHC Class I Gene Therapy in Organ Transplantation: Prevention of Antibody-Mediated Hyperacute Heart Allograft Rejection in Highly Sensitized Rat Recipients

  2000cites this paper
• Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: Hepatocyte‐expressed membrane‐bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats

  2000cites this paper
• Die Form von spenderspezifischem, durch Hepatozyten exprimiertem MHC Klasse I Antigen ist entscheidend für die IL-2 Antwort von T-Helferzellen

  1999cites this paper